Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer.
Rachael L SherrerZachary A GlaserJennifer B GordetskyJeffrey W NixKristin K PorterSoroush Rais-BahramiPublished in: Prostate cancer and prostatic diseases (2018)
BP-MRI for the evaluation of PCa and for guiding MRI/US fusion-targeted biopsy has the advantages of reducing cost, time, and contrast exposure of MP-MRI by eliminating the DCE phase. These benefits are realized without forfeiting valuable diagnostic information, as shown by similar cancer detection rates of BP-MRI and MP-MRI in this study, particularly for clinically significant cases of PCa.